USE of anti-obesity medications or AOMs and the associated demand for protein rich foods is a global trend set to benefit ...

This article does not attempt to predict the potential policies that the new administration and Congress might pursue or how ...

Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cance ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...

The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.

Obesity medications promise transformative care, but financial and systemic barriers limit access for those most in need.

Anti-obesity medication: these are the surprising effects of taking Ozempic and Mounjaro - As weight loss jabs becomes ...